Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Cancer Research

• Publication date

  2014-11-19

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25520873PMCID PMC4266717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional activity of c-Jun is critical for the suppression of AR function.

  2013cited by this paper
• Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.

  2011cited by this paper
• Radiotherapy and short-term androgen deprivation for localized prostate cancer.

  2011cited by this paper
• Treatment strategies for high-risk locally advanced prostate cancer

  2010cited by this paper
• Life and death partners: apoptosis, autophagy and the cross-talk between them

  2009cited by this paper
• RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.

  2009cited by this paper
• CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy

  2009cited by this paper
• Duration of androgen suppression in the treatment of prostate cancer.

  2009cited by this paper
• Treatment failure after primary and salvage therapy for prostate cancer

  2008cited by this paper
• Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.

  2008cited by this paper
• Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy.

  2008cited by this paper
• Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.

  2008cited by this paper
• Clinical implications of neuroendocrine differentiation in prostate cancer

  2007cited by this paper
• Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease.

  2007cited by this paper
• cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis

  2007cited by this paper
• CREB − a real culprit in oncogenesis

  2007cited by this paper
• Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

  2007cited by this paper
• Clonogenic assay of cells in vitro

  2006cited by this paper
• Interference with 3',5'-cyclic adenosine monophosphate response element binding protein stimulates apoptosis through aberrant cell cycle progression and checkpoint activation.

  2006cited by this paper
• Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients.

  2005influential reference
• Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.

  2005cited by this paper
• Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.

  2005cited by this paper
• Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions.

  2004cited by this paper
• Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images

  2004cited by this paper
• Neuroendocrine cells in prostate cancer.

  2004cited by this paper
• Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

  2003cited by this paper
• Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma

  2003cited by this paper
• Detection of mutation in transgenic CHO cells using green fluorescent protein as a reporter.

  2002cited by this paper
• Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.

  2002cited by this paper
• A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.

  2001cited by this paper
• Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.

  2001cited by this paper
• Neuroendocrine cells in human prostate over‐express the anti‐apoptosis protein survivin

  2001cited by this paper
• Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: Protein kinase A downregulation and cytoplasmic export of CRE-binding proteins

  2001cited by this paper
• Transcriptional regulation by the phosphorylation-dependent factor CREB

  2001influential reference
• New concepts in radiation‐induced apoptosis: ‘premitotic apoptosis’ and ‘postmitotic apoptosis’

  2001cited by this paper
• CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

  1999cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma

  1999cited by this paper
• Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.

  1999cited by this paper
• Analysis of molecular mechanisms controlling neuroendocrine cell specific transcription of the chromogranin A gene.

  1998influential reference
• Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment.

  1998cited by this paper
• A Dominant-Negative Inhibitor of CREB Reveals that It Is a General Mediator of Stimulus-Dependent Transcription of c-fos

  1998cited by this paper
• Expression of the gene encoding transcription factor cyclic adenosine 3',5'-monophosphate (cAMP) response element-binding protein (CREB): regulation by follicle-stimulating hormone-induced cAMP signaling in primary rat Sertoli cells.

  1995cited by this paper
• Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors.

  1994cited by this paper
• Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma

  1993cited by this paper
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

  1992cited by this paper
• Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.

  1992cited by this paper
• Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

  1992cited by this paper

• Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer

  2025cites this paper
• The universal role of adaptive transcription in health and disease

  2024cites this paper
• Understanding the molecular regulators of neuroendocrine prostate cancer.

  2024cites this paper
• Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST

  2024cites this paper
• Cyclic AMP-regulatory element-binding protein: a novel UV-targeted transcription factor in skin cancer

  2024cites this paper
• Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST

  2023cites this paper
• JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer

  2023cites this paper
• Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer

  2022cites this paper
• cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach

  2022cites this paper
• Targeting protein arginine methyltransferase 5 (PRMT5) suppresses radiation-induced neuroendocrine differentiation and sensitizes prostate cancer cells to radiation.

  2022cites this paper
• Epigenetic mechanisms underlying prostate cancer radioresistance

  2021cites this paper
• The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

  2021cites this paper
• The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

  2021cites this paper
• New horizons from novel therapies in malignant pleural mesothelioma

  2020cites this paper
• What turns CREB on? And off? And why does it matter?

  2020cites this paper
• Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report

  2020influential citation
• Ablation of LGR4 signaling enhances radiation sensitivity of prostate cancer cells.

  2020cites this paper
• Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer

  2020cites this paper
• Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance

  2020cites this paper
• Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells.

  2019cites this paper
• hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen

  2019cites this paper
• RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway

  2019cites this paper
• Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play

  2019cites this paper
• Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer.

  2018cites this paper
• Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression

  2018cites this paper
• Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers

  2018cites this paper
• Inhibition of ERK1/2 or AKT Activity Equally Enhances Radiation Sensitization in B16F10 Cells

  2018cites this paper
• MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG

  2018cites this paper
• Regulation of Cancer Cell Responsiveness to Ionizing Radiation Treatment by Cyclic AMP Response Element Binding Nuclear Transcription Factor

  2017influential citation
• NOVEL MECHANISMS OF β-ADRENERGIC SIGNALING IN PROSTATE CANCER PROGRESSION

  2016cites this paper
• Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective

  2016cites this paper
• GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells

  2016cites this paper
• The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.

  2016cites this paper
• Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target

  2016cites this paper
• Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.

  2015cites this paper
• Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure

  2015cites this paper